Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action
The use of pharmaceuticals for colon cancer treatment has been increasingly personalized, in part due to the development of new molecular tools. In this review, we discuss the old and new colon cancer chemotherapeutics, and the parameters that have been shown to be predictive of efficacy and safety...
Saved in:
Main Authors: | Wafik S. El-Deiry (Author), Christina Leah B. Kline (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics
by: Anna D. Louie, et al.
Published: (2021) -
Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
by: Wen-I Chang, et al.
Published: (2022) -
Targeting the Integrated Stress Response in Cancer Therapy
by: Xiaobing Tian, et al.
Published: (2021) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021) -
Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies
by: Nicholas R. Liguori, et al.
Published: (2021)